| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 14,797 | 11,020 | ||
| Short-term investments | 23,131 | 33,765 | ||
| Prepaid expenses and other current assets | 686 | 1,578 | ||
| License agreement receivable | 10,000 | 10,000 | ||
| License agreement contract asset | 0 | 0 | ||
| Restricted cash | 80 | 135 | ||
| Total current assets | 48,694 | 56,498 | ||
| Investments | 0 | 1,736 | ||
| Deferred offering costs | 417 | 417 | ||
| Restricted cash | 109 | 109 | ||
| Operating lease right-of-use asset | 1,851 | 1,934 | ||
| Total assets | 51,071 | 60,694 | ||
| Accounts payable | 3,467 | 6,172 | ||
| Accrued expenses | 2,774 | 2,477 | ||
| Deferred revenue, current portion | 1,765 | 1,770 | ||
| Operating lease liability, current portion | 463 | 444 | ||
| Convertible debt | 0 | 0 | ||
| Total current liabilities | 8,469 | 10,863 | ||
| Deferred revenue | 807 | 515 | ||
| Warrant liability | 3,544 | 2,904 | ||
| Operating lease liability | 1,821 | 1,945 | ||
| Total liabilities | 14,641 | 16,227 | ||
| Common stock, 0.001 par value, 150,000,000 shares authorized as of september 30, 2025 and december 31, 2024 41,956,724 and 37,973,991 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 45 | 42 | ||
| Additional paid-in capital | 433,787 | 433,236 | ||
| Accumulated deficit | -397,402 | -388,811 | ||
| Total stockholders' equity | 36,430 | 44,467 | ||
| Total liabilities and stockholders equity | 51,071 | 60,694 | ||
SCYNEXIS INC (SCYX)
SCYNEXIS INC (SCYX)